UCB 24/30 MTNUCB 24/30 MTNUCB 24/30 MTN

UCB 24/30 MTN

No trades
See on Supercharts

Key terms


Outstanding amount
‪500.00 M‬EUR
Face value
100,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
4.25% (Fixed)
Coupon frequency
Annual
Yield to maturity
3.86%
Maturity date
Mar 20, 2030
Term to maturity
5 years

About UCB 24/30 MTN


Issuer
Sector
Health Technology
Home page
Issue date
Mar 20, 2024
ISIN
BE0390119825
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.